C Ryan Tomlin PharmD BCPS AAHIVP Clinical Pharmacist HIV Medicine Outline Side Effects Concerns with Pharmacokinetics Medication Errors Resistance 2 Side Effects 3 Medication Side Effects ID: 916662
Download Presentation The PPT/PDF document "Barrier to HIV Medication Adherence" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Barrier to HIV Medication Adherence
C. Ryan Tomlin, Pharm.D., BCPS, AAHIVP
Clinical Pharmacist – HIV Medicine
Slide2Outline
Side Effects
Concerns with Pharmacokinetics
Medication ErrorsResistance
2
Slide3Side Effects
3
Slide4Medication Side Effects
Definition: A secondary, often undesirable effect of a medication
Most importance barrier to medication adherence
Adverse effects are decreasingBetter tolerated medicationsMore knowledge of medication effects
4
Slide5What Case Managers Need to Know
General medication side effects
Educate patients on self-monitoring
Help limit premature discontinuation of medicationsWhen something should be brought to the providers attention urgently
5
Slide6Antiretroviral Side Effects
Montessori V. et al, CMAJ 2004;170:229-38
6
Slide7Most Common Side Effects Leading to Treatment Discontinuation
Hypersensitivity reaction
0
5
10
15
20
25
30
Nausea
Diarrhea
Vomiting
Gastrointestinal
Dysphagia
Headache
Insomnia
Fatigue
Dizziness
Neuropathy
Anemia
Neutrophil
Adverse event
27%
18%
16%
12%
11%
7%
7%
6%
6%
5%
5%
5%
5%
7
O’Brien ME, et al.
J
Acquir
Immune
Defic
Syndr
.
2003;34:407-414.
Slide8Key Points
Evaluate all patients for potential side effects
Preexisting conditions can have higher risks
DiabetesHyperlipidemiaKidney diseaseHematologic problemsOne shoe does not fit all – Side effects will vary by patient
8
Slide9Common Questions To Ask
How long has this side effect be going on?
How long have you been on your current medication?
Does anything make the side effect worse or better? (examples: sleep? food?)Has anything else changed? Other new medications? Sleep or eating habits?
9
Slide10Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Fewer side effects with newer medications
Lactic Acidosis - Buildup of lactic acid
Less common with tenofovir, abacavir, lamivudine, emtricitabine
Lipoatrophy
10
Slide11Specific NRTI Side Effects
Abacavir
– Hypersensitivity reaction
Occurs is 5-8% of patientsFever, rash, vomiting, shortness of breathMust contact provider right awayTest for HLA*B 5701 prior to starting abacavir
Tenofovir
DF – Long-term side effects
Kidney dysfunction
Bone mineral loss
Not seen with
tenofovir
alafenamide
11
Slide12Non-Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Fewer side effects with newer agents
Rash
Refer to providerLiver toxicityProvider will monitor routine labsGastrointestinalNausea and diarrhea
Will usually improve after a few weeks
12
Slide13Efavirenz
(
Sustiva
®)Also in Atripla®Dizziness/DrowsinessTake at bedtime
Sleep abnormalities
Vivid dreams, Insomnia, Oversleeping
Take on an empty stomach
Worsen depression
False+ for THC in urine drug screen
Letter for patient
Require confirmatory test
13
Slide14Protease Inhibitors (PIs)
Gastrointestinal (Nausea/Diarrhea)
Take with food
Symptoms often resolve over first few weeksHyperlipidemia / Glucose IntoleranceLess common with newer agentsDiet and exerciseLipohypertrophy
uncommon now
14
Slide15Specific PI Side Effects
Atazanavir
– Asymptomatic Hyperbilirubinemia
Looks like jaundice, but no liver damageCosmetic side effects can be bothersome to patientsDarunavir – Rash Medication contains a sulfa component
Incidence of rash is similar between people with and without sulfa allergies
Report side effect to MD
15
Slide16Integrase
Inhibitors
Well tolerated
Most common side effects are GINauseaDiarrheaHeadacheMuscle AcheRefer to medical provider
16
Slide17Immune Reconstitution Inflammatory Syndrome (IRIS)
Inflammatory reaction at the site of a preexisting infection due to immune system recovery following initiation of ART
Immune system recovers and realizes there is an infection
SymptomsFever, Tiredness/fatigue, Weight lossAdditional symptoms vary based on underlying infection
17
Slide18IRIS Risk Factors
Low CD4 count prior to medications
Large increase in CD4 following medication
High VL prior to medicationsLarge decrease in VL following medicationsHistory of AIDS-related infectionHistory of fungal infection
18
Slide19IRIS Management
Continue antiretrovirals in most cases
Anti-inflammatory medications
NSAIDsCorticosteroidsTreat the underlying infection
19
Slide20ARV Side Effects
Educate patients
What side effects to expect
How to handle common side effectsFollow-up phone call 2 weeks after startingEmpower patientsAsk questionsCall with problems
20
Slide21Concerns with Pharmacokinetics
21
Slide22How medications move through the bodyWhat the body does to the medications
22
What is Pharmacokinetics?
Amount of Medication in the Blood
Time
Absorption
Elimination
Slide23Why Do I Need To Know Pharmacokinetics?
To understand what medication factors impact adherence
To know why taking medication a specified way is important
Time of dayWith/without food
23
Slide24Consequences of Taking Medication Inappropriately
Toxic Concentrations
More Side Effects
Viral Resistance
Efficacy
Minimally Effective Concentration
24
Dose
Dose
Amount of Medication in the Blood
Time
Slide25Pharmacokinetic Categories - ADME
A
bsorption – How does the body take in the medication?
Distribution – Once in the body, where does the medication go?Metabolism – How does the body change or break down the medication?Elimination – How does the body remove the medication?
25
Slide26Absorption: Routes
Oral
Intravenous
BuccalTransdermalSublingualEye, Ear, NoseRectalIntramuscularSubcutaneousInhalationVaginal
Intrathecal
Intrasynovial
Intracardiac
26
Slide27Absorption: Impact of Food
Food can increase how much medication gets into the body – for better or worse
27
Reyataz
with Food
Good
Atripla
with Food
Bad
Slide28Distribution
Transfer of medication from one place to another
Some medication stays in the blood, some goes to tissues and organs
28
Slide29Long-Acting Injectable Medications
Cabotegravir
and
Rilpivirine are being studied as once-monthly injectionsAbsorption Route – Intramuscular (Intragluteal)Distribution – Very Very Slowly
29
Slide30Metabolism
Many medications are broken down in the liver
This can turn an active medication into waste
This can turn an inactive medication into an active, usable form
How a medication in metabolized is important for determining drug interactions
30
Slide31Metabolism: Drug Interactions
Many medication are broken down with the same tools in the liver
When given together they compete and the levels of one medication can increase
31
Slide32“Boosted” Protease Inhibitors (PIs)
Boosters prevent breakdown of PIs in the liver
Result is higher blood levels of the PI for a longer time
32
Slide33Excretion
How medication is removed from the body
Kidneys
Bile / FecesLungs33
Slide34Excretion: Dosing Changes
Patients with damaged kidneys may require lower doses since less medication is being removed
34
Amount of Medication in the Blood
Time
Damaged Kidneys
Healthy Kidneys
Slide35Medication Errors
35
Slide36Common Causes
Patient Misuse
Poor understating of directions
No knowledge of interactions / OTC medicationsDon’t fully grasp importancePoor Communication/ProceduresLack of standardization with ARTTransitions in care
Lack of Product Knowledge/Training
Specialty area of medicine
36
http://www.fda.gov/Drugs/DrugSafety/MedicationErrors/default.htm
Slide37Common Errors Made
By Healthcare Professionals
Wrong Medication
Wrong DoseMissing Medications / InformationDrug Interactions
Slide38Wrong Medication: Look/Sound Alike
Retrovir
/Ritonavir
Nelfinavir/NevirapineViracept/Viramune/
Viread
Invirase
/
Efavirenz
Combivir
/
Trizivir
Isentress
/
Intelence
Prezista
/
PrezcobixReyataz/EvotazGray J et al. AIDS Patient Care and STDs 205;19:803-12. Faragon J et al. AIDS Read 2003;13:268-8038
Slide39Wrong Medication: Combo Pills
Single medication given in place of the combination
Abacavir dispensed in place of Epzicom (abacavir/lamivudine)
Tivicay (dolutegravir) dispensed in place of Triumeq (dolutegravir/abacavir/lamivudine)
39
Slide40Wrong Medication: Abbreviations
HIV providers
LOVE
abbreviationsAZT – Zidovudine / AzidothymidineAztreonamAzathioprine
Azithromycin
ART
Example regimen:
ABC/3TC, TDF, DRV/r
How many medications?
How many different prescriptions?
40
Slide41Wrong Medication Dose or Frequency
Medication dosage make need to be changed based on:
Patient’s kidney function
Past medication resistancePatient’s weight (pediatric patients)Pregnancy
Slide42Missing Medications/Information
All patients on therapy should have 3 ART
Doesn’t have to be 3 pills
Don’t take one without the othersRitonavir & Cobicistat don’t countJuluca and
Dovato
(2 medications) are the only exceptions
Don’t forget to document time of day taken and relation to food
Ask the patient!
Once daily doesn’t always mean 0900
42
Slide43Drug Interactions: Liver Enzymes
Enzymes in the liver can be either induced or inhibited
Adapted from Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9
th
ed.
43
Slide44Medications Metabolized In The Liver
Antidepressants
Anxiolytics
Cholesterol Medications – StatinsPDE-5 Inhibitors – Viagra, CialisInhaled/Intranasal CorticosteroidsContraceptivesPain Medications – Methadone
Slide45Common Errors Made
By Patients
Wrong Administration Time
Missed / Late DosesDrug Interactions With Over The Counter Medications / Herbal Medications
Slide46Wrong Administration Time: Food
Change in Total Drug Level Based on Food
Antiretroviral
With Food
Empty Stomach
Atazanavir
- 70%
Indinavir
- 77%
Nelfinavir
- 3 fold
Saquinavir
- 6 fold
Tipranavir
- 30%
Darunavir
- 30%
Efavirenz
+ 28% (+79%Cmax)
Rilpivirine
- 40%
46
Reyataz
[Product Insert]. Princeton, NJ: Bristol-Myer Squibb;2010.
Crixivan
[Product Insert]. Whitehouse Station, NJ: Merck & Co;2009.
Viracept
[Product Insert]. La Jolla, CA:
Agouron
; 2008.
Invirase
[Product Insert]. Nutley, NJ: Roche Labs;2010.
Aptivus
[Product Insert]. Ridgefield, CT:
Boehringher
Ingelheim;2009.
Prezista
[Product Insert]. Raritan, NJ: Janssen Products;2006.
Sustiva
[Product Insert]. Princeton,
NJ:Bristol-Myer
Squibb;2010.
Edurant
[Product Insert]. Titusville, NJ: Janssen Products;2011
Slide47Missed / Late Doses
Missed doses can cause:
Detectable viral loads
Increased risk of HIV transmissionDevelopment of HIV resistanceLate doses are better than doses missed entirelyIn general, follow the “Half Way” ruleIf you remember and it is less than half way till your next dose, take it
Never double up on medications
Slide48Drug Interactions: Heartburn Medication
Atazanavir
and
rilpivirine require stomach acid for absorption
Atazanavir
Rilpivirine
Proton
Pump Inhibitors (ex: Prilosec)
Separate by 12 hours
AVOID
H2 Antagonists (ex: Zantac)
Separate by 10 hours
Cannot be given 12 hours before or 4 hours after RPV
Antacids
(ex: TUMS)
Cannot be given 1 hour before or 2 hours after ATV
Cannot be given 2 hour before or 4 hours after RPV
48
DHHS Guidelines for the Use of ARV Agents in HIV-1-Infected Adults and Adolescents, 5-1-15.
Slide49Drug Interactions: Inhaled/Intranasal Corticosteroids
49
DHHS Guidelines for the Use of ARV Agents in HIV-1-Infected Adults and Adolescents, 5-1-15.
Slide50Polyvalent cations: Zinc, Iron, Calcium, Aluminum, Magnesium (ZICAM)
Found in antacids, laxatives, supplements, prenatal vitamins,
sucralfate
Can bind and inactivate raltegravir, elvitegravir, dolutegravir, and bictegravirEach medication has unique guidance on how to avoid this interaction
Drug Interactions: Polyvalent
Cations
50
DHHS Guidelines for the Use of ARV Agents in HIV-1-Infected Adults and Adolescents, 5-1-15.
Slide51No information ≠ No interactionMinimal information
No studies conducted
Monitor how each medication in metabolized
3A4 inducers: St. John’s wort, gingko biloba extract, echinacea
Drug Interactions: Herbal Products
51
Slide52Prevention: What Can You Do?
Educate yourself
Keep communication open with all members of the patients healthcare team
Avoid abbreviationsPay attention to timing and how medications should be takenAsk about new medications / Check for interactions
52
Slide53Prevention: How Can We Empower Clients?
Education! Education! Education!
Goals of therapy
Combinations medicationsAdherence as it relates to resistanceDirections (twice daily vs every 12 hours?)Food requirements
Common drug interactions
Encourage patients to always ask questions of ALL healthcare providers
53
Slide54Prevention: How Can We Implement System-Wide Processes?
Encourage patients to have only 1 pharmacy
As available, limit barriers to communication between health-systems, medical records, pharmacy, etc.
Be familiar with, or have cheat sheets available of both brand and generic medication namesWhen in doubt, ask the patient!
54